Mesenchymal stem cell treatment for IPF-time for phase 2 trials?

Lancet Respir Med. 2017 Jun;5(6):472-473. doi: 10.1016/S2213-2600(17)30180-7. Epub 2017 May 26.

Authors

Katerina M Antoniou¹, Konstantinos Karagiannis², Eliza Tsitoura², Nikos Tzanakis²

Affiliations

¹ Department of Respiratory Medicine and Laboratory of Molecular and Cellular Pulmonology, Faculty of Medicine, University of Crete, Crete, Greece. Electronic address: kantoniou@med.uoc.gr.
² Department of Respiratory Medicine and Laboratory of Molecular and Cellular Pulmonology, Faculty of Medicine, University of Crete, Crete, Greece.

PMID: 28664848
DOI: 10.1016/S2213-2600(17)30180-7

No abstract available

Publication types

Review

MeSH terms

Clinical Trials, Phase II as Topic*
Humans
Idiopathic Pulmonary Fibrosis / therapy*
Mesenchymal Stem Cell Transplantation*